HD-tDCS for Phonological Impairment in Aphasia (NCT06010030) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
HD-tDCS for Phonological Impairment in Aphasia
United States200 participantsStarted 2023-10-03
Plain-language summary
This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients must be 18 or older.
Patients may not be older than 85.
Patients must have a language deficit from left-sided focal neurologic damage (e.g. stroke, tumor).
Patients must be adults and have English-language fluency.
Patients must be eligible to undergo MRI.
Beyond meeting the inclusion criteria, no preference will be given on the basis of race, ethnicity or gender.
Exclusion Criteria:
* Advanced neurodegenerative disease (i.e. Stage 3 Alzheimer's disease)
Neurologic disease (e.g. idiopathic epilepsy, seizure disorders that are not well managed, Parkinson's disease, ALS),
Severe psychopathology (e.g. schizophrenia, bipolar disorder, acute major depressive episode)
Suspected or diagnosed uncorrectable hearing or vision difficulties, or developmental disabilities (i.e. intellectual disability or learning disability).
Contraindications to MRI such as claustrophobia, implanted electronic devices, MRI-incompatible metal in the body, extreme obesity, pregnancy, inability to lie flat, inability to see or hear stimulus materials.
Younger than 18 or older than 85.
\< 6 months post tumor resection.
What they're measuring
1
Behavioral outcome
Timeframe: Upon the completion of therapy cycle (a cycle consists of 10 intervention days) and 10 weeks post completion of therapy